natgillin/translations-raw huggingface dataset:
This means that Abseamed is similar to and contains the same active substance as a biological medicine that is already authorised in the European Union (EU), which is known as the ‘reference medicine’.
See tähendab, et Abseamed on sarnane bioloogilise ravimiga (võrdlusravimiga), millel juba on Euroopa Liidus müügiluba ning mis sisaldab sama toimeainet.
This means that Accofil is similar to a biological medicine (also known as the ‘reference medicine’) that is already authorised in the European Union (EU).
See tähendab, et Accofil sarnaneb bioloogilise ravimiga (võrdlusravimiga), millel juba on Euroopa Liidus müügiluba.
This means that Actelsar HCT is similar to a ‘reference medicine’ already authorised in the European Union (EU) called MicardisPlus.
See tähendab, et Actelsar HCT on sarnane võrdlusravimiga MicardisPlus, millel juba on Euroopa Liidus müügiluba.
This means that Aerivio Spiromax is similar to a ‘reference medicine’ called Seretide Diskus (also known as Seretide Accuhaler), which contains the same active substances.
See tähendab, et Aerivio Spiromax on sarnane võrdlusravimiga Seretide Diskus (sama mis Seretide Accuhaler), mis sisaldab samu toimeaineid.
This means that after taking Tafinlar, you must wait at least 1 hour before eating, or after eating, you must wait at least 2 hours before taking Tafinlar.
See tähendab, et pärast Tafinlar’i võtmist peate olema vähemalt tund aega söömata, või pärast söömist peate ootama vähemalt 2 tundi, enne kui võtate Tafinlar’i
This means that Airexar Spiromax is similar to a ‘reference medicine’ called Seretide Diskus (also known as Seretide Accuhaler), which contains the same active substances.
See tähendab, et Airexar Spiromax on sarnane võrdlusravimiga Seretide Diskus (sama mis Seretide Accuhaler), mis sisaldab samu toimeaineid.
This means that Amlodipine/Valsartan Mylan is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Exforge.
See tähendab, et Amlodipine/Valsartan Mylan on sarnane võrdlusravimiga Exforge, millel juba on Euroopa Liidus müügiluba.
This means that ammonia builds up in the body.
See tähendab, et ammoniaak koguneb kehasse.
This means that Aripiprazole Accord is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Abilify.
See tähendab, et Aripiprazole Accord on sarnane võrdlusravimiga Abilify, millel juba on Euroopa Liidus müügiluba.
This means that aripiprazole acts like dopamine and 5- hydroxytryptamine by activating these receptors, but less strongly than the neurotransmitters.
See tähendab, et aripiprasool mõjub nagu dopamiin ja 5- hüdroksütrüptamiin, aktiveerides neid retseptoreid, kuid vähem kui neurotransmitterid.
This means that aripiprazole acts like dopamine and 5-hydroxytryptamine by activating these receptors, but less strongly than the neurotransmitters.
See tähendab, et aripiprasool mõjub nagu dopamiin ja 5- hüdroksütrüptamiin, aktiveerides neid retseptoreid, kuid vähem kui neurotransmitterid.
This means that Aripiprazole Mylan Pharma is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Abilify.
See tähendab, et Aripiprazole Mylan Pharma on sarnane võrdlusravimiga Abilify, millel juba on Euroopa Liidus müügiluba.
This means that Aripiprazole Zentiva is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Abilify.
See tähendab, et Aripiprazole Zentiva on sarnane võrdlusravimiga Abilify, millel juba on Euroopa Liidus müügiluba.
This means that Armisarte is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Alimta, but it is available in a different form.
See tähendab, et Armisarte sarnaneb võrdlusravimiga Alimta, millel juba on Euroopa Liidus müügiluba, kuid selle ravimvorm on erinev.
This means that Atosiban SUN is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Tractocile.
See tähendab, et Atosiban SUN on sarnane võrdlusravimiga Tractocile, millel juba on Euroopa Liidus müügiluba.
This means that because CAPS is a rare disease, it has not been possible to obtain complete information about Ilaris.
See tähendab, et kuna CAPS-sündroomid on haruldane haigus, ei olnud võimalik saada Ilarise kohta täielikku teavet.
This means that because of the rarity of this disease and for ethical reasons it has been impossible perform a placebo-controlled clinical trials and to get complete information on this medicine.
See tähendab, et harvaesineva haiguse tõttu ja eetilistel põhjustel, mis ei ole võimaldanud platseebokontrolliga uuringu läbiviimist, ei ole olnud võimalik saada ravimpreparaadi kohta täielikku teavet.
This means that because of the rarity of this disease and for ethical reasons it has been impossible to get complete information on this medicine.
See tähendab, et harvaesineva haiguse tõttu ja eetilistel põhjustel ei ole olnud võimalik saada täielikku informatsiooni selle ravimi kohta.
This means that because of the rarity of this disease it has been impossible to get complete information on this medicine.
See tähendab, et harvaesineva haiguse tõttu ei ole olnud võimalik saada ravimi kohta täielikku teavet.
This means that because of the rarity of this disease it has been impossible to get complete information on this medicine.
See tähendab, et harvaesineva haiguse tõttu ei ole olnud võimalik saada täielikku informatsiooni selle ravimi kohta.
This means that because the disease is rare, it has not been possible to obtain complete information about Ceplene.
Et see haigus esineb harva, ei ole olnud võimalik saada Ceplene kohta täielikku teavet.
This means that because the disease is rare, it has not been possible to obtain complete information about Vedrop.
Et see haigus esineb harva, ei ole olnud võimalik saada Vedropi kohta täielikku teavet.
This means that Bemfola is similar to a biological medicine (also known as the ‘reference medicine’) that is already authorised in the European Union (EU).
See tähendab, et Bemfola sarnaneb bioloogilise ravimiga (võrdlusravim), millel juba on Euroopa Liidus müügiluba.
This means that Binocrit is similar to and contains the same active substance as a biological medicine that is already authorised in the European Union (EU), which is known as the ‘reference medicine’.
See tähendab, et Binocrit on sarnane bioloogilise ravimiga (võrdlusravimiga), millel juba on Euroopa Liidus müügiluba ning mis sisaldab sama toimeainet.
This means that Biograstim is similar to a biological medicine that is already authorised in the European Union (EU) and contains the same active substance (also known as the ‘reference medicine’).
See tähendab, et Biograstim on sarnane bioloogilise ravimiga, millel on juba Euroopa Liidus müügiluba ning mis sisaldab sama toimeainet (nimetatakse ka võrdlusravimiks).
This means that Bortezomib Accord is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Velcade.
See tähendab, et Bortezomib Accord on sarnane võrdlusravimiga Velcade, millel juba on Euroopa Liidus müügiluba.
This means that Bortezomib Hospira is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Velcade.
See tähendab, et Bortezomib Hospira on sarnane võrdlusravimiga Velcade, millel juba on Euroopa Liidus müügiluba.
This means that Bortezomib Sun is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Velcade.
See tähendab, et Bortezomib Sun on sarnane võrdlusravimiga Velcade, millel juba on Euroopa Liidus müügiluba.
This means that Busulfan Fresenius Kabi is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Busilvex.
See tähendab, et Busulfan Fresenius Kabi on sarnane võrdlusravimiga Busilvex, millel juba on Euroopa Liidus müügiluba.
This means that Capecitabine SUN is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Xeloda.
See tähendab, et Capecitabine SUN on sarnane võrdlusravimiga Xeloda, millel juba on Euroopa Liidus müügiluba.
This means that Capecitabine Teva is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Xeloda.
See tähendab, et Capecitabine Teva on sarnane võrdlusravimiga Xeloda, millel juba on Euroopa Liidus müügiluba.
This means that Caspofungin Accord is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Cancidas.
See tähendab, et Caspofungin Accord on sarnane võrdlusravimiga Cancidas, millel juba on Euroopa Liidus müügiluba.
This means that Ciambra is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Alimta.
See tähendab, et Ciambra on sarnane võrdlusravimiga Alimta, millel juba on Euroopa Liidus müügiluba.
This means that Cinacalcet Mylan is similar to a ‘reference medicine’ already authorised in the European Union (EU).
See tähendab, et Cinacalcet Mylan on sarnane võrdlusravimiga, millel juba on Euroopa Liidus müügiluba.
This means that clofarabine takes the place of adenine in the body, and interferes with the enzymes involved in making genetic material, called ‘DNA polymerase’ and ‘RNA reductase’.
Selle tõttu asendab klofarabiin organismis adeniini ning häirib geenimaterjali tekkes osalevate ensüümide DNA-reduktaasi ja DNA-polümeraasi toimet.
This means that Clopidogrel 1A Pharma is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Plavix.
See tähendab, et Clopidogrel 1A Pharma on sarnane võrdlusravimiga Plavix, millel juba on Euroopa Liidus müügiluba.
This means that Clopidogrel Acino is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Plavix.
See tähendab, et Clopidogrel Acino on sarnane võrdlusravimiga Plavix, millel juba on Euroopa Liidus müügiluba.
This means that Clopidogrel Acino Pharma GmbH is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Plavix.
See tähendab, et Clopidogrel Acino Pharma GmbH on sarnane võrdlusravimiga Plavix, millel juba on Euroopa Liidus müügiluba.
This means that Clopidogrel Acino Pharma is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Plavix.
See tähendab, et Clopidogrel Acino Pharma on sarnane võrdlusravimiga Plavix, millel juba on Euroopa Liidus müügiluba.
This means that Clopidogrel Apotex is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Plavix.
See tähendab, et Clopidogrel Apotex on sarnane võrdlusravimiga Plavix, millel juba on Euroopa Liidus müügiluba.
This means that Clopidogrel BGR is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Plavix.
See tähendab, et Clopidogrel BGR on sarnane võrdlusravimiga Plavix, millel juba on Euroopa Liidus müügiluba.
This means that Clopidogrel DURA is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Plavix.
See tähendab, et Clopidogrel DURA on sarnane võrdlusravimiga Plavix, millel juba on Euroopa Liidus müügiluba.
This means that Clopidogrel HCS is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Plavix.
See tähendab, et Clopidogrel HCS on sarnane võrdlusravimiga Plavix, millel juba on Euroopa Liidus müügiluba.
This means that Clopidogrel Hexal is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Plavix.
See tähendab, et Clopidogrel Hexal on sarnane võrdlusravimiga Plavix, millel juba on Euroopa Liidus müügiluba.
This means that Clopidogrel Krka is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Plavix.
See tähendab, et Clopidogrel Krka on sarnane võrdlusravimiga Plavix, millel juba on Euroopa Liidus müügiluba.
This means that Clopidogrel Mylan is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Plavix.
See tähendab, et Clopidogrel Mylan on sarnane võrdlusravimiga Plavix, millel juba on Euroopa Liidus müügiluba.
This means that Clopidogrel Qualimed is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Plavix.
See tähendab, et Clopidogrel Qualimed on sarnane võrdlusravimiga Plavix, millel juba on Euroopa Liidus müügiluba.
This means that Clopidogrel ratiopharm GmbH is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Plavix.
See tähendab, et Clopidogrel ratiopharm GmbH on sarnane võrdlusravimiga Plavix, millel juba on Euroopa Liidus müügiluba.
This means that Clopidogrel ratiopharm is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Plavix.
See tähendab, et Clopidogrel ratiopharm on sarnane võrdlusravimiga Plavix, millel juba on Euroopa Liidus müügiluba.
This means that Clopidogrel Sandoz is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Plavix.
See tähendab, et Clopidogrel Sandoz on sarnane võrdlusravimiga Plavix, millel juba on Euroopa Liidus müügiluba.
This means that Clopidogrel TAD is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Plavix.
See tähendab, et Clopidogrel TAD on sarnane võrdlusravimiga Plavix, millel juba on Euroopa Liidus müügiluba.
This means that Clopidogrel Teva Generics B.V. is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Plavix.
See tähendab, et Clopidogrel Teva Generics B.V. on sarnane võrdlusravimiga Plavix, millel juba on Euroopa Liidus müügiluba.
This means that Clopidogrel Teva is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Plavix.
See tähendab, et Clopidogrel Teva on sarnane võrdlusravimiga Plavix, millel juba on Euroopa Liidus müügiluba.
This means that Clopidogrel Teva Pharma B.V. is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Plavix.
See tähendab, et Clopidogrel Teva Pharma B.V. on sarnane võrdlusravimiga Plavix, millel juba on Euroopa Liidus müügiluba.
This means that Clopidogrel Teva Pharma is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Plavix.
See tähendab, et Clopidogrel Teva Pharma on sarnane võrdlusravimiga Plavix, millel juba on Euroopa Liidus müügiluba.
This means that darbepoetin alfa has a longer duration of action, and can be given less often than natural erythropoietin.
See tähendab, et alfadarbepoetiini toimeaeg on pikem ja seda saab manustada harvem.
This means that Dasselta is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Aerius.
See tähendab, et Dasselta on sarnane võrdlusravimiga Aerius, millel juba on Euroopa Liidus müügiluba.
This means that Desloratadine Actavis is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Aerius.
See tähendab, et Desloratadine Actavis on sarnane võrdlusravimiga Aerius, millel juba on Euroopa Liidus müügiluba.
This means that Desloratadine ratiopharm is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Aerius.
See tähendab, et Desloratadine ratiopharm on sarnane võrdlusravimiga Aerius, millel juba on Euroopa Liidus müügiluba.
This means that Desloratadine Teva is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Aerius.
See tähendab, et Desloratadine Teva on sarnane võrdlusravimiga Aerius, millel juba on Euroopa Liidus müügiluba.
This means that Docefrez is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Taxotere.
See tähendab, et Docefrez on sarnane võrdlusravimiga Taxotere, millel juba on Euroopa Liidus müügiluba.
This means that Docetaxel Kabi is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Taxotere.
See tähendab, et Docetaxel Kabi on sarnane võrdlusravimiga Taxotere, millel juba on Euroopa Liidus müügiluba.
This means that Docetaxel Mylan is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Taxotere.
See tähendab, et Docetaxel Mylan on sarnane võrdlusravimiga Taxotere, millel juba on Euroopa Liidus müügiluba.
This means that Docetaxel Teva is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Taxotere.
See tähendab, et Docetaxel Teva on sarnane võrdlusravimiga Taxotere, millel juba on Euroopa Liidus müügiluba.
This means that Docetaxel Teva Pharma is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Taxotere.
See tähendab, et Docetaxel Teva Pharma on sarnane võrdlusravimiga Taxotere, millel juba on Euroopa Liidus müügiluba.
This means that due to scientific reasons it has been impossible to get complete information on this medicine.
See tähendab, et teaduslikel põhjustel ei ole olnud võimalik saada ravimi kohta täielikku teavet.
This means that due to the lack of smallpox disease in the world it has not been possible to obtain complete information on this medicinal product.
See tähendab, et rõugete puudumise tõttu maailmas ei ole olnud võimalik saada ravimpreparaadi kohta täielikku teavet.
This means that due to the rarity of the disease and for ethical reasons it has not been possible to obtain complete information on this medicinal product.
See tähendab, et harvaesineva haiguse tõttu ja eetilistel põhjustel ei ole olnud võimalik saada täielikku informatsiooni ravimpreparaadi kohta.
This means that due to the rarity of the disease and for ethical reasons it has not been possible to obtain complete information on this medicinal product.
See tähendab, et harvaesineva haiguse tõttu ja eetilistel põhjustel ei ole olnud võimalik saada täielikku teavet ravimpreparaadi kohta.
This means that due to the rarity of the disease it has not been possible to obtain complete information on this medicinal product.
See tähendab, et kuna haigus on haruldane, ei ole olnud võimalik saada ravimi kohta täielikku teavet.
This means that due to the rarity of the disease it has not been possible to obtain complete information on this medicine.
See tähendab, et harvaesineva haiguse tõttu ei ole olnud võimalik saada täielikku informatsiooni selle ravimi kohta.
This means that due to the rarity of this disease it has not been possible to obtain complete information on this medicine.
See tähendab, et harvaesineva haiguse tõttu ei ole olnud võimalik saada ravimpreparaadi kohta täielikku teavet.
This means that Duloxetine Mylan is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Cymbalta.
See tähendab, et Duloxetine Mylan on sarnane võrdlusravimiga Cymbalta, millel juba on Euroopa Liidus müügiluba.
This means that Duloxetine Zentiva is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Cymbalta.
See tähendab, et Duloxetine Zentiva on sarnane võrdlusravimiga Cymbalta, millel juba on Euroopa Liidus müügiluba.
This means that Ebilfumin is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Tamiflu.
See tähendab, et Ebilfumin on sarnane võrdlusravimiga Tamiflu, millel juba on Euroopa Liidus müügiluba.
This means that Efavirenz Teva is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Sustiva.
See tähendab, et Efavirenz Teva on sarnane võrdlusravimiga Sustiva, millel juba on Euroopa Liidus müügiluba.
This means that Entacapone Teva is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Comtess.
See tähendab, et Entacapone Teva on sarnane võrdlusravimiga Comtess, millel juba on Euroopa Liidus müügiluba.
This means that Envarsus is similar to a ‘reference medicine’ that contains the same active substance but Envarsus has been formulated in a different way and is available at different doses.
See tähendab, et Envarsus sarnaneb sama toimeainet sisaldava võrdlusravimiga, aga Envarsus on teistmoodi formuleeritud ja see on saadaval erinevates annustes.
This means that Enyglid is similar to a ‘reference medicine’ already authorised in the European Union (EU) called NovoNorm.
See tähendab, et Enyglid on sarnane võrdlusravimiga NovoNorm, millel juba on Euroopa Liidus müügiluba.
This means that Epoetin Alfa Hexal is similar to and contains the same active substance as a biological medicine that is already authorised in the European Union (EU), which is known as the ‘reference medicine’.
See tähendab, et Epoetin Alfa Hexal on sarnane bioloogilise ravimiga (võrdlusravimiga), millel juba on Euroopa Liidus müügiluba ning mis sisaldab sama toimeainet.
This means that Eptifibatide Accord is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Integrilin.
See tähendab, et Eptifibatide Accord on sarnane võrdlusravimiga Integrilin, millel juba on Euroopa Liidus müügiluba.
This means that Filgrastim Hexal is similar to a biological medicine that is already authorised in the European Union (EU) and contains the same active substance (also known as the ‘reference medicine’).
See tähendab, et Filgrastim Hexal on sarnane bioloogilise ravimiga (võrdlusravimiga), millel juba on Euroopa Liidus müügiluba ning mis sisaldab sama toimeainet.
This means that Filgrastim ratiopharm is similar to a biological medicine that is already authorised in the European Union (EU) and contains the same active substance (also known as the ‘reference medicine’).
See tähendab, et Filgrastim ratiopharm on sarnane bioloogilise ravimiga, millel on juba Euroopa Liidus müügiluba ning mis sisaldab sama toimeainet (nimetatakse ka võrdlusravimiks).
This means that Flixabi is similar to a biological medicine (also known as the ‘reference medicine’) that is already authorised in the European Union (EU).
See tähendab, et Flixabi sarnaneb bioloogilise ravimiga (võrdlusravimiga), millel juba on Euroopa Liidus müügiluba.
This means that for scientific reasons it has been impossible to get complete information on this medicine.
See tähendab, et teaduslikel põhjustel ei ole olnud võimalik saada täielikku informatsiooni selle ravimi kohta.
This means that for scientific reasons it has not been possible to obtain complete information on this medicinal product.
See tähendab, et teaduslikel põhjustel ei ole olnud võimalik saada ravimpreparaadi kohta täielikku teavet.
This means that further evidence on this medicinal product is awaited, in particular about Fampyra’s benefits beyond its effects on walking speed and with respect to early identification of responders.
See tähendab, et selle ravimpreparaadi omaduste kohta oodatakse lisatõendeid, eriti Fampyra positiivse mõju kohta muule kui kõndimiskiirusele ja ravile allujate varase identifitseerimise suhtes.
This means that further evidence on this medicinal product is awaited.
See tähendab, et oodatakse lisatõendusmaterjali selle ravimpreparaadi omaduste kohta.
This means that Glidipion is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Actos.
See tähendab, et Glidipion on sarnane võrdlusravimiga Actos, millel juba on Euroopa Liidus müügiluba.
This means that Grastofil is similar to a biological medicine (the ‘reference medicine’) that is already authorised in the European Union (EU) and that Grastofil and the reference medicine contain the same active substance.
See tähendab, et Grastofil on sarnane bioloogilise ravimiga (võrdlusravimiga), millel juba on Euroopa Liidus müügiluba ning mis sisaldab sama toimeainet.
This means that Grepid is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Plavix.
See tähendab, et Grepid on sarnane võrdlusravimiga Plavix, millel juba on Euroopa Liidus müügiluba.
This means that Iasibon is similar to a ‘reference medicine’ already authorised in the European Union (EU) called Bondronat.
See tähendab, et Iasibon on sarnane võrdlusravimiga Bondronat, millel juba on Euroopa Liidus müügiluba.
This means that Ibandronic Acid Sandoz is similar to a ‘reference medicine’ already authorised in the European Union (EU).
See tähendab, et Ibandronic Acid Sandoz on sarnane võrdlusravimiga, millel juba on Euroopa Liidus müügiluba.
This means that Ibandronic Acid Teva is similar to a ‘reference medicine’ already authorised in the European Union (EU).
See tähendab, et Ibandronic Acid Teva on sarnane võrdlusravimiga, millel juba on Euroopa Liidus müügiluba.